Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this prospective study, patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy were included. The aim of this study is to assess the prevalence of tubal histopathological abnormalities such as Serous Tubal Intraepithelial Carcinoma (STIC) and tumor protein 53 (p53) signatures) as well as the prevalence of perioperative and postoperative complications related to opportunistic laparoscopic salpingectomy in a low risk population. The hypothesis is that prophylactic salpingectomy during benign laparoscopic hysterectomy is both feasible and innocuous. Peri- and postoperative complications, duration of salpingectomy and post-salpingectomy blood loss, histopathological and immunohistochemical analysis with anti-p53 antibody were evaluated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology

NCT03187327

Salpingectomy Hysterectomy

COMPLETED

Impact of Salpingectomy on Ovarian Reserve

NCT02284711

Laparoscopic Salpingectomy

COMPLETED NA

Long-term Outcomes After Laparoscopic Subtotal and Total Hysterectomy

NCT05421156

Hysterectomy

NOT_YET_RECRUITING

Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy

NCT01893086

Benign Uterine Disease

COMPLETED PHASE3

Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule

NCT05741554

Serous Ovarian Carcinoma Low Grade Serous Ovarian Carcinoma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Laparoscopic Hysterectomy Systematic Salpingectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Benign laparoscopic hysterectomy

Patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy

Histopathologic tube anomalies

Intervention Type OTHER

Assessment of prevalence of histopathologic tube anomalies (Serous Tubal Intraepithelial Carcinoma (STIC) or tumor protein 53 (p53) lesion)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Histopathologic tube anomalies

Assessment of prevalence of histopathologic tube anomalies (Serous Tubal Intraepithelial Carcinoma (STIC) or tumor protein 53 (p53) lesion)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy

Exclusion Criteria

* Hysterectomy in a context of gynecologic cancer
* Hysterectomy not carried out using laparoscopy
* Fimbriated end missing or damaged or impossible for pathologist to analyze

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No